{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:16:13Z","timestamp":1793470573304,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejso.2025.109716","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T16:50:47Z","timestamp":1740588647000},"page":"109716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A retrospective study evaluating surgical upstaging rates in low-risk DCIS patients meeting the eligibility criteria for active surveillance trials"],"prefix":"10.1016","volume":"51","author":[{"given":"Jose","family":"Vila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Farante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-3572","authenticated-orcid":false,"given":"Francisco","family":"Ripoll-Orts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Lissidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-4002","authenticated-orcid":false,"given":"Matteo","family":"Lazzeroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Frassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Rodr\u00edguez del Busto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ejso.2025.109716_bib1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","article-title":"Ductal carcinoma in situ of the breast","volume":"350","author":"Burstein","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2025.109716_bib2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/cncr.21652","article-title":"Pathologic findings from the breast cancer surveillance consortium","volume":"106","author":"Weaver","year":"2006","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2025.109716_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","article-title":"NCCN Guidelines\u00ae insights: breast cancer, version 4.2021","volume":"19","author":"Gradishar","year":"2021","journal-title":"J National Compr Cancer Netw Jnccn"},{"key":"10.1016\/j.ejso.2025.109716_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejca.2009.12.004","article-title":"No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN)","volume":"46","author":"Farante","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2025.109716_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/tbj.12295","article-title":"Are all patients with ductal carcinoma in situ of the breast candidates for radiotherapy after breast conservative treatment? Institute of European Oncology guidelines","volume":"20","author":"Farante","year":"2014","journal-title":"Breast J"},{"key":"10.1016\/j.ejso.2025.109716_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejso.2021.10.030","article-title":"Advances and controversies in management of breast ductal carcinoma in situ (DCIS)","volume":"48","author":"Farante","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.109716_bib7","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.ejso.2025.109716_bib8","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2025.109716_bib9","doi-asserted-by":"crossref","first-page":"TPS603","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS603","article-title":"The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA)","volume":"37","author":"Kanbayashi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109716_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejso.2025.109716_bib11","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low\u2010grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long\u2010term follow\u2010up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2025.109716_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.breast.2022.01.001","article-title":"Unresected screen-detected ductal carcinoma in situ: outcomes of 311 women in the Forget-Me-Not 2 study","volume":"61","author":"Maxwell","year":"2022","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ejso.2025.109716_bib13","first-page":"140","article-title":"Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia","volume":"11","author":"Tavassoli","year":"1998","journal-title":"Mod Pathol"},{"issue":"25","key":"10.1016\/j.ejso.2025.109716_bib14","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1200\/JCO.2007.11.9453","article-title":"Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: big 1-98","volume":"25","author":"Viale","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109716_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41523-022-00420-2","article-title":"Is conservative management of ductal carcinoma in situ risky?","volume":"8","author":"Zheng","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.109716_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/cancers14020370","article-title":"A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with low-grade ductal carcinoma in situ of the breast","volume":"14","author":"Nicosia","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejso.2025.109716_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/cancers13040868","article-title":"Complete removal of the lesion as a guidance in the management of patients with breast ductal carcinoma in situ","volume":"13","author":"Nicosia","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ejso.2025.109716_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamasurg.2017.2181","article-title":"Factors associated with underestimation of invasive cancer in patients with ductal carcinoma in situ: precautions for active surveillance","volume":"152","author":"Chavez de Paz Villanueva","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2025.109716_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jamaoncol.2019.4849","article-title":"De-escalating breast cancer surgery-where is the tipping point?","volume":"6","author":"Morrow","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.ejso.2025.109716_bib20","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.21614\/chirurgia.116.5.suppl.S65","article-title":"De-escalating treatment for ductal carcinoma in situ","volume":"116","author":"Montagna","year":"2021","journal-title":"Chirurgia"},{"issue":"11","key":"10.1016\/j.ejso.2025.109716_bib21","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1245\/s10434-016-5268-2","article-title":"Do LORIS trial eligibility criteria identify a ductal carcinoma in situ patient population at low risk of upgrade to invasive carcinoma?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.109716_bib22","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1245\/s10434-020-08576-6","article-title":"Do eligibility criteria for ductal carcinoma in situ (DCIS) active surveillance trials identify patients at low risk for upgrade to invasive carcinoma?","volume":"27","author":"Oseni","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.109716_bib23","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109716_bib24","article-title":"Radiogenomics for predicting underestimation of invasiveness in ductal carcinoma in situ (DCIS) diagnosed with vacuum assisted breast biopsy: study rationale and design [abstract]","volume":"vol. 15","author":"Lazzeroni","year":"2022"},{"issue":"16","key":"10.1016\/j.ejso.2025.109716_bib25","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.3390\/cancers13163962","article-title":"On behalf of the grand challenge precision consortium. Preferences of treatment strategies among women with low-risk DCIS and oncologists","volume":"13","author":"Byng","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2025.109716_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113276","article-title":"Active surveillance versus treatment in low-risk DCIS: women's preferences in the LORD-trial","volume":"192","author":"Schmitz","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2025.109716_bib27","article-title":"Non-surgical treatment for ductal carcinoma in situ of the breasts - a prospective study on patient's perspective","volume":"26","author":"Co","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ejso.2025.109716_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.breast.2015.10.011","article-title":"Eliminating \"ductal carcinoma in situ\" and \"lobular carcinoma in situ\" (DCIS and LCIS) terminology in clinical breast practice: the cognitive psychology point of view","volume":"25","author":"Pravettoni","year":"2016","journal-title":"Breast"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T10:45:01Z","timestamp":1750502701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0748798325001441"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109716","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective study evaluating surgical upstaging rates in low-risk DCIS patients meeting the eligibility criteria for active surveillance trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109716"}}